Just days before the full COVID-19 lockdown came into force, REHAP partners from Tecnalia, RINA and Insight Media met to plan the next phase of exploitation and business planning for key REHAP results.

REHAP coordinator Aitor Bario and exploitation planning expert Amaia Sopelana, both from Tecnalia, were joined in Derio, Spain by dissemination and exploitation work package leader William Davis who was in the country making the new project film. They were all joined online by Andrea Leoncini from RINA in Italy, where the lockdown had already started.

The discussion focussed on the identified exploitable results to have emerged from the REHAP project and how these will be divided into those with clear commercial potential, those that need specific action to carry forward and those with potential for further research.

Those with clear commercial potential will now benefit from a process of full business planning, to be led by RINA and taking advantage of the life cycle and cost analysis already carried out. Working with the relevant partners for each of these key exploitable results, RINA will develop these plans for the products, new technologies (processes etc) or new services. Plans need to be realistic about this potential and focus on those that have confirmed interest from partners for further exploitation after the project. Four results have been identified that :

  • Companies plan to use
  • There is a clear business opportunity for them
  • They have clear market potential

Business strategy planning will contain the following information:

  • Description of the product/solution, its novel nature and the value it adds to existing products or solutions
  • Market analysis
  • The team to be involved in the commercialisation
  • The business model for how the ER will generate commercial value (CANVAS)
  • Cost benefit analysis
  • Risk assessment
  • Commercialisation roadmap

REHAP partners involved in these results are NOVAMONT, BIOSYNCAUCHO, RAMPF, FORESA, CROMOGENIA

 

Eight further exploitable results identified are also promising, with realistic expectations for their further exploitation after the project ends. Exploitation action plans will be developed for each of these and will provide clear indications of what the partners who own them plan or want to do with them. These plans will include:

  • Plans or strategy to develop a new product
  • New research needed to advance to the next level
  • Any licencing plans

Partners involved in these action plans are VTT, BBEPP and Tecnalia.

 

The final four results are those for which have been identified as having potential for further development that will make them more commercially exploitable or those with further research potential. For these exploitation competitiveness strategies will be developed. These will be simple one-page documents that show what improvements or developments will be necessary to the ER to improve its competitiveness.

Partners involved in this work will be FORESA, COLLANTI, LAFARGE and RAMPH.

 

All these plans will not only be valuable for the companies involved in this phase of the project in terms of maximising their return on investment by exploiting commercial opportunities, but they will also offer potential for collaboration with other companies in the sector or those wishing to take research potential to the next level.